LifeStance Health Group, Inc. is 1.8x more valuable than GeneDx Holdings Corp. by market capitalization ($3.02 B vs $1.65 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LFST | WGS |
|---|---|---|
| Market cap | $3.02 B | $1.65 B |
| US-listed rank | #1798 | #2251 |
| Revenue (latest FY) | $1.42B | $427.54M |
| Net income (latest FY) | $9.66M | -$21.00M |
| Net margin | 0.7% | -4.9% |
| P/E (trailing FY) | 312.1 | - |
| SEC filings | 452 | 748 |
LifeStance Health Group, Inc. is 1.8x more valuable than GeneDx Holdings Corp. by market capitalization ($3.02 B vs $1.65 B).
In their latest fiscal years, LifeStance Health Group, Inc. reported $1.42B in revenue while GeneDx Holdings Corp. reported $427.54M.
Full pages: LifeStance Health Group, Inc. and GeneDx Holdings Corp., or browse the full rankings.